# Kenneth Kalunian

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kenneth-kalunian/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,059 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 75 |
| i10-index | 178 |
| Last Known Institution | University of California System |
| OpenAlex ID | https://openalex.org/A5013861508 |
| ORCID iD | 0000-0003-0261-3102 |
| Works | 379 |

## Researcher papers

Showing 12 of 16.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus](https://scholariq.org/papers/combined-oral-contraceptives-in-women-with-systemic-lupus-erythematosus/)
- [Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus](https://scholariq.org/papers/anifrolumab-an-anti-interferon-receptor-monoclonal-antibody-in-moderate-to/)
- [The immune cell landscape in kidneys of patients with lupus nephritis](https://scholariq.org/papers/the-immune-cell-landscape-in-kidneys-of-patients-with-lupus-nephritis/)
- [The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus](https://scholariq.org/papers/the-reliability-of-the-systemic-lupus-international-collaborating-clinics/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis](https://scholariq.org/papers/a-multicenter-randomized-double-blind-placebo-controlled-trial-of-adjuvant/)
- [Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort](https://scholariq.org/papers/factors-associated-with-damage-accrual-in-patients-with-systemic-lupus/)
- [Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial](https://scholariq.org/papers/baricitinib-for-systemic-lupus-erythematosus-a-double-blind-randomised-placebo/)
- [Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study](https://scholariq.org/papers/sifalimumab-an-anti-interferon-monoclonal-antibody-in-moderate-to-severe/)
- [Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus](https://scholariq.org/papers/prospective-analysis-of-neuropsychiatric-events-in-an-international-disease/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

## Researcher university

- [University of California System](https://scholariq.org/institutions/university-of-california-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.